BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29379322)

  • 1. Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure.
    Robson JC; Dawson J; Cronholm PF; Milman N; Kellom KS; Ashdown S; Easley E; Farrar JT; Gebhart D; Lanier G; McAlear CA; Peck J; Luqmani RA; Shea JA; Tomasson G; Merkel PA
    Patient Relat Outcome Meas; 2018; 9():17-34. PubMed ID: 29379322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Robson JC; Dawson J; Cronholm PF; Ashdown S; Easley E; Kellom KS; Gebhart D; Lanier G; Milman N; Peck J; Luqmani RA; Shea JA; Tomasson G; Merkel PA
    Rheumatol Int; 2018 Apr; 38(4):675-682. PubMed ID: 29124398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient perceptions of health-related quality of life in giant cell arteritis: international development of a disease-specific patient-reported outcome measure.
    Robson JC; Almeida C; Dawson J; Bromhead A; Dures E; Guly C; Hoon E; Mackie S; Ndosi M; Pauling J; Hill C
    Rheumatology (Oxford); 2021 Oct; 60(10):4671-4680. PubMed ID: 33528002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire.
    Robson JC; Dawson J; Doll H; Cronholm PF; Milman N; Kellom K; Ashdown S; Easley E; Gebhart D; Lanier G; Mills J; Peck J; Luqmani RA; Shea J; Tomasson G; Merkel PA
    Ann Rheum Dis; 2018 Aug; 77(8):1157-1164. PubMed ID: 29695498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring the impact of steroid therapy on health-related quality of life in patients with rheumatic diseases: international development of a glucocorticoid treatment-specific patient-reported outcome measure.
    Bridgewater S; Shepherd MA; Dawson J; Richards P; Silverthorne C; Ndosi M; Almeida C; Black RJ; Cheah JTL; Dures E; Ghosh N; Hoon EA; Lyne S; Navarro-Millan I; Pearce-Fisher D; Ruediger C; Tieu J; Yip K; Mackie SL; Goodman S; Hill C; Robson JC
    Rheumatology (Oxford); 2023 Nov; 62(11):3565-3575. PubMed ID: 36840642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do ANCA-associated vasculitides and IgG4-related disease really overlap or not?
    Erden A; Bolek EC; Yardimci KG; Kilic L; Bilgen SA; Karadag O
    Int J Rheum Dis; 2019 Oct; 22(10):1926-1932. PubMed ID: 31571413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in patients with ANCA vasculitides compared to rheumatoid arthritis: a cross-sectional comparative study.
    Panagiotopoulos A; Thomas K; Argyriou E; Chalkia A; Kapsala N; Koutsianas C; Mavrea E; Petras D; Boumpas DT; Vassilopoulos D
    Rheumatology (Oxford); 2024 Feb; 63(2):399-406. PubMed ID: 37171857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.
    Hruskova Z; Stel VS; Jayne D; Aasarød K; De Meester J; Ekstrand A; Eller K; Heaf JG; Hoitsma A; Martos Jimenéz C; Ravani P; Wanner C; Tesar V; Jager KJ
    Am J Kidney Dis; 2015 Oct; 66(4):613-20. PubMed ID: 25975963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics, the diagnostic criteria and management recommendation of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) proposed by Japan Otological Society.
    Harabuchi Y; Kishibe K; Tateyama K; Morita Y; Yoshida N; Okada M; Kunimoto Y; Watanabe T; Inagaki A; Yoshida T; Imaizumi M; Nakamura T; Matsunobu T; Kobayashi S; Iino Y; Murakami S; Takahashi H; Tono T
    Auris Nasus Larynx; 2021 Feb; 48(1):2-14. PubMed ID: 32768313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous Manifestations of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Micheletti RG; Chiesa Fuxench Z; Craven A; Watts RA; Luqmani RA; Merkel PA;
    Arthritis Rheumatol; 2020 Oct; 72(10):1741-1747. PubMed ID: 32419292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG anti-Pentraxin 3 antibodies are a novel biomarker of ANCA-associated vasculitis and better identify patients with eosinophilic granulomatosis with polyangiitis.
    Padoan R; Gatto M; Ghirardello A; Tonello M; Franco C; Felicetti M; Schiavon F; Doria A
    J Autoimmun; 2021 Nov; 124():102725. PubMed ID: 34534841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
    Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Otologic Manifestations in Patients with ANCA Associated Vasculitis-Comparative Analysis among Microscopic Polyangiitis, Granulomatosis with Polyangiitis and Eosinophilic Granulomatosis with Polyangiitis].
    Kawashima Y; Noguchi Y; Ito T; Mizushima K; Takahashi M; Kitamura K; Tsutsumi T
    Nihon Jibiinkoka Gakkai Kaiho; 2016 Feb; 119(2):110-7. PubMed ID: 27149708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasculitis for the internist: focus on ANCA-associated vasculitis.
    Chaigne B; Guillevin L
    Intern Emerg Med; 2017 Aug; 12(5):577-585. PubMed ID: 28623488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ANCA-Associated Vasculitis: Core Curriculum 2020.
    Geetha D; Jefferson JA
    Am J Kidney Dis; 2020 Jan; 75(1):124-137. PubMed ID: 31358311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical analysis of 46 cases with antineutrophil cytoplasmic antibody-associated vasculitis].
    Zhang Q; Zhou HQ; Li YH; Guo J; Xu PH; Lu MH; Liu XL; Wang L; Li SG
    Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(27):2146-9. PubMed ID: 27464538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis.
    Beketova TV
    Ter Arkh; 2018 May; 90(5):13-22. PubMed ID: 30701885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No evident association of nasal carriage of Staphylococcus aureus or its small-colony variants with cotrimoxazole use or ANCA-associated vasculitis relapses.
    Tan BK; Crabol Y; Tasse J; Laurent F; Nekkab N; Vinter C; Puéchal X; Guillevin L
    Rheumatology (Oxford); 2020 Jan; 59(1):77-83. PubMed ID: 31834404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary manifestations and outcomes in paediatric ANCA-associated vasculitis: a single-centre experience.
    Sayad E; Vogel TP; Guillerman RP; Spielberg D; McNeill DM; De Guzman M; Orman G; Silva-Carmona M
    Rheumatology (Oxford); 2021 Jul; 60(7):3199-3208. PubMed ID: 33355338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
    Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.